Quest Diagnostics Inc. logo

Quest Diagnostics Inc. (DGX)

Market Open
5 Dec, 17:36
NYSE NYSE
$
182. 41
-1.77
-0.96%
$
21.2B Market Cap
20.12 P/E Ratio
3% Div Yield
191,950 Volume
8.71 Eps
$ 184.18
Previous Close
Day Range
182.26 184.17
Year Range
148.7 197.55
Want to track DGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 55 days

Summary

DGX trading today lower at $182.41, a decrease of 0.96% from yesterday's close, completing a monthly decrease of -0.76% or $1.39. Over the past 12 months, DGX stock gained 20.04%.
DGX pays dividends to its shareholders, with the most recent payment made on Oct 20, 2025. The next announced payment will be in In 1 month on Jan 28, 2026 for a total of $0.8.
The last earnings report, released on Oct 28, 2025, missed the consensus estimates by -2.51%. On average, the company has fell short of earnings expectations by -0.79%, based on the last three reports. The next scheduled earnings report is due on Jan 29, 2026.
Quest Diagnostics Inc. has completed 2 stock splits, with the recent split occurring on Jun 21, 2005.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

DGX Chart

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 days ago
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term

Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 week ago
Should You Hold Quest Diagnostics Stock in Your Portfolio for Now?

Should You Hold Quest Diagnostics Stock in Your Portfolio for Now?

DGX pushes growth through acquisitions and advanced diagnostics even as rising debt and tough competition pressure its outlook.

Zacks | 1 week ago

Quest Diagnostics Inc. (DGX) FAQ

What is the stock price today?

The current price is $182.41.

On which exchange is it traded?

Quest Diagnostics Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is DGX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3%.

What is its market cap?

As of today, the market cap is 21.2B.

What is the earnings per share?

The EPS is 2.36.

When is the next earnings date?

The next earnings report will release on Jan 29, 2026.

Has Quest Diagnostics Inc. ever had a stock split?

Quest Diagnostics Inc. had 2 splits and the recent split was on Jun 21, 2005.

Quest Diagnostics Inc. Profile

- Industry
- Sector
James E. Davis CEO
NYSE Exchange
74834L100 CUSIP
US Country
55,000 Employees
13 Jan 2026 Last Dividend
21 Jun 2005 Last Split
17 Dec 1996 IPO Date

Overview

Quest Diagnostics Incorporated, established in 1967 and based in Secaucus, New Jersey, is a prominent provider of diagnostic testing, information, and services both in the United States and internationally. The company operates with the mission to deliver critical diagnostic insights that lead to informed healthcare decisions. Using its extensive network of laboratories, patient service centers, and healthcare professionals, Quest Diagnostics offers a wide range of diagnostic information services. These services cater to a diverse clientele including physicians, hospitals, patients, health plans, government agencies, employers, and pharmaceutical companies. Through its flagship Quest Diagnostics brand and others such as AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum, the company aims to improve health outcomes by making better information available to the healthcare ecosystem.

Products and Services

  • Diagnostic Information Services
  • These encompass routine and non-routine clinical tests, advanced clinical testing, and anatomic pathology testing. Quest Diagnostics utilizes a vast array of technological platforms to provide critical diagnostic information that supports disease prevention, diagnosis, treatment, and management.

  • Risk Assessment Services for Life Insurance Industry
  • Quest Diagnostics provides comprehensive risk assessment services tailored to the needs of the life insurance sector. These services are designed to help insurance companies evaluate the health risks of policy applicants through a variety of diagnostic tests and assessments.

  • Healthcare Information Technology Solutions
  • Offering cutting-edge information technology solutions, Quest Diagnostics helps healthcare organizations and clinicians enhance efficiency and patient care. These solutions encompass a wide range of IT services designed to facilitate the secure exchange of health information, improve lab ordering processes, and streamline patient record management.

Contact Information

Address: 500 Plaza Drive
Phone: 973 520 2700